Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy, tolerance and safety of tacrolimus
0.03% ointment in the treatment of intractable allergic conjunctivitis.